Literature DB >> 32736294

State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.

Ryan K McBain1, Eunice C Wong2, Joshua Breslau3, Amy L Shearer2, Matthew S Cefalu2, Elizabeth Roth2, M Audrey Burnam2, Rebecca L Collins2.   

Abstract

BACKGROUND: Cannabis use and cannabis use disorder are more prevalent in U.S. states with medical marijuana laws (MMLs), as well as among individuals with elevated psychological distress. We investigated whether adults with moderate and serious psychological distress experienced greater levels of cannabis use and/or disorder in states with MMLs compared to states without MMLs.
METHODS: National Survey of Drug Use and Health data (2013-2017) were used to compare past-month cannabis use, daily cannabis use, and cannabis use disorder prevalence among adults with moderate and serious psychological distress in states with versus without MMLs. We executed pooled multivariable logistic regression analyses to test main effects of distress, MMLs and their interaction, after adjustment.
RESULTS: Compared to states without MMLs, states with MMLs had higher adjusted prevalence of past-month use (11.1 % vs. 6.8 %), daily use (4.0 % vs. 2.2 %), and disorder (1.7 % vs. 1.2 %). Adults with moderate and serious psychological distress had greater adjusted odds of any use (AORs of 1.72 and 2.22, respectively) and of disorder (AORs of 2.17 and 2.94, respectively), compared to those with no/mild distress. We did not find evidence of an interaction between MMLs and distress category for any outcome.
CONCLUSIONS: Associations between elevated distress and cannabis use patterns are no greater in states with MML. However, cannabis use is more prevalent in MML states. Thus, higher base rates of cannabis use and disorder among adults with elevated distress are proportionally magnified in these states.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CUD; Cannabis; Marijuana legalization laws; Mental health; Policy analysis; Psychological distress

Year:  2020        PMID: 32736294      PMCID: PMC7502494          DOI: 10.1016/j.drugalcdep.2020.108191

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  49 in total

1.  Screening for serious mental illness in the general population.

Authors:  Ronald C Kessler; Peggy R Barker; Lisa J Colpe; Joan F Epstein; Joseph C Gfroerer; Eva Hiripi; Mary J Howes; Sharon-Lise T Normand; Ronald W Manderscheid; Ellen E Walters; Alan M Zaslavsky
Journal:  Arch Gen Psychiatry       Date:  2003-02

2.  Do medical marijuana laws increase marijuana use? Replication study and extension.

Authors:  Sam Harper; Erin C Strumpf; Jay S Kaufman
Journal:  Ann Epidemiol       Date:  2012-01-29       Impact factor: 3.797

3.  Recent Trends in the Prevalence of Marijuana Use and Associated Disorders in the United States.

Authors:  Richard A Grucza; Arpana Agrawal; Melissa J Krauss; Patricia A Cavazos-Rehg; Laura J Bierut
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

4.  Use of marijuana exclusively for medical purposes.

Authors:  Melanie M Wall; Jun Liu; Deborah S Hasin; Carlos Blanco; Mark Olfson
Journal:  Drug Alcohol Depend       Date:  2018-12-04       Impact factor: 4.492

5.  Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016.

Authors:  Magdalena Cerdá; Christine Mauro; Ava Hamilton; Natalie S Levy; Julián Santaella-Tenorio; Deborah Hasin; Melanie M Wall; Katherine M Keyes; Silvia S Martins
Journal:  JAMA Psychiatry       Date:  2020-02-01       Impact factor: 21.596

6.  Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder.

Authors:  Arthur Robin Williams; Julian Santaella-Tenorio; Christine M Mauro; Frances R Levin; Silvia S Martins
Journal:  Addiction       Date:  2017-07-17       Impact factor: 6.526

7.  Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.

Authors:  Margaret Haney; A Eden Evins
Journal:  Neuropsychopharmacology       Date:  2015-08-19       Impact factor: 7.853

8.  Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D.

Authors:  Ashley C Bradford; W David Bradford
Journal:  Health Aff (Millwood)       Date:  2016-07-01       Impact factor: 6.301

Review 9.  Sources of Error in Substance Use Prevalence Surveys.

Authors:  Timothy P Johnson
Journal:  Int Sch Res Notices       Date:  2014-11-05

10.  US Epidemiology of Cannabis Use and Associated Problems.

Authors:  Deborah S Hasin
Journal:  Neuropsychopharmacology       Date:  2017-08-30       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.